ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselImmunovant Sciences GmbH
Immunovant Sciences GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Immunovant Sciences GmbH is a clinical-stage immunology company developing anti‑FcRn therapies, including IMVT‑1402 and batoclimab, to reduce pathogenic IgG autoantibodies in autoimmune diseases. The product candidates are described as fully human monoclonal antibodies intended for subcutaneous administration with dosing that may be tailored to disease stage and severity.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Immunovant Sciences GmbH

Pharmaceutical Industry
✓ Offered3
Development of anti-FcRn therapies
Development of anti-neonatal Fc receptor approaches to promote IgG catabolism in autoimmune diseases; focused on an investigational therapy with Imeroprubart (IMVT-1402).
Clinical development in autoimmune diseases
Clinical studies in the therapeutic areas of Graves’ Disease, Myasthenia Gravis, CIDP, Rheumatoid Arthritis, Sjögren’s Disease and Cutaneous Lupus Erythematosus.
Patient and study information
Information on autoimmune diseases, therapeutic areas and clinical trial participation; including overviews of Graves’ Disease, MG, CIDP, Sjögren’s Disease and CLE.
Trust & reputation

ranQ Trust Score of Immunovant Sciences GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Immunovant Sciences GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Immunovant Sciences GmbH scores 77.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.79.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Immunovant Sciences GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Immunovant Sciences GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Immunovant Sciences GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Immunovant Sciences GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Immunovant Sciences GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Immunovant Sciences GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Immunovant Sciences GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Viaduktstr. 8
4051 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-297.527.393
Founded
2018 · 8 years
Last commercial register change
July 15, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AS
    Autolus Switzerland AG
    Basel
    MT
    Mysthera Therapeutics AG
    Basel
    IG
    inhive Group (Switzerland) AG
    Basel
    ST
    Synendos Therapeutics AG
    Basel
    IP
    Ironwood Pharmaceuticals GmbH
    Basel
    PI
    PAREXEL International (CH) AG
    Basel
    SR
    SFL Regulatory Affairs & Scientific Communication GmbH
    Basel
    SB
    SOTIO Biotech AG
    Basel